Related Funds
Fund Name | Location |
ASE Global Group | New York, New York, United States |
Care Capital | New Jersey, Princeton, United States |
Edison International | California, Rosemead, United States |
First Reserve Corporation | Connecticut, Greenwich, United States |
Hengqinhexiang Venture | China, Guangdong, Zhuhai |
Hims & Hers | California, San Francisco, United States |
HTG | Japan, Osaka, Osaka Prefecture |
ITI Energy | - |
Key Venture Partners | Boston, Massachusetts, United States |
Lucent Venture Partners | California, Palo Alto, United States |
Muniu Touzi | China, Guangdong, Shenzhen |
Rockefeller Financial Services | California, Los Angeles, United States |
Septeni | Chiyoda, Japan |
Start it Labs, LLC | Bellevue, United States, Washington |
Strandview Capital | California, El Segundo, United States |
UBS Asset Management | England, London, United Kingdom |
Waaree | India, Maharashtra, Mumbai |
Walmart | Arkansas, Bentonville, United States |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Odyssey Therapeutics | $168M | 13 Oct 2022 | Cambridge, Massachusetts, United States | ||
Umoja Biopharma | $210M | 15 Jun 2021 | Seattle, Washington, United States | ||
$100M | 14 Dec 2020 | San Diego, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Odyssey Therapeutics | $168M | 13 Oct 2022 | Cambridge, Massachusetts, United States | ||
Umoja Biopharma | $210M | 15 Jun 2021 | Seattle, Washington, United States | ||
$100M | 14 Dec 2020 | San Diego, California, United States |